SUN PHARMACEUTICAL INDUSTRIES
Back to Income Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹9,576 Cr | ₹8,474 Cr | ₹3,273 Cr | ₹2,904 Cr | ₹3,765 Cr |
What is the latest Consolidated Net Profit of SUN PHARMACEUTICAL INDUSTRIES ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹9,576 Cr |
Mar2023 | ₹8,474 Cr |
Mar2022 | ₹3,273 Cr |
Mar2021 | ₹2,904 Cr |
Mar2020 | ₹3,765 Cr |
How is Consolidated Net Profit of SUN PHARMACEUTICAL INDUSTRIES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹9,576 Cr | 13.01 | |
Mar2023 | ₹8,474 Cr | 158.91 | |
Mar2022 | ₹3,273 Cr | 12.70 | |
Mar2021 | ₹2,904 Cr | -22.87 | |
Mar2020 | ₹3,765 Cr | - |
Compare Consolidated Net Profit of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹404,414.0 Cr | -0.2% | -2.9% | 12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,572.0 Cr | 0.3% | 6.5% | 49% | Stock Analytics | |
CIPLA | ₹123,329.0 Cr | 1.1% | 1.8% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,396.0 Cr | -0.2% | 9.5% | 12.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,956.0 Cr | 1.9% | 0.4% | 14% | Stock Analytics | |
MANKIND PHARMA | ₹97,734.2 Cr | -0.4% | -7.8% | 9.9% | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | -0.2% |
-2.9% |
12.6% |
SENSEX | -0.8% |
-0.9% |
6.9% |
You may also like the below Video Courses